PDGF-β receptor and PKC have no effect on angiotensin II-induced JAK2 and STAT1 phosphorylation in vascular smooth muscle cells under high glucose condition

References

• Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes 1993, 42, 8–11.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340, 115–126.
   PubMed Web of Science ®Google Scholar
• Srivastava AK. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review). Int J Mol Med 2002, 9, 85–89.
   PubMed Web of Science ®Google Scholar
• Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998, 83, 1182–1191.
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48, 1–9.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 1992, 187, 552–560.
   PubMed Web of Science ®Google Scholar
• Sharpe PC, Yue KK, Catherwood MA, McMaster D, Trimble ER. The effects of glucose-induced oxidative stress on growth and extracellular matrix gene expression of vascular smooth muscle cells. Diabetologia 1998, 41, 1210–1219.
   PubMedGoogle Scholar
• Ballinger ML, Thomas MC, Nigro J, Ivey ME, Dilley RJ, Little PJ. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. Kidney Int 2005, 68, 2756–2765.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9, 180–186.
   PubMed Web of Science ®Google Scholar
• Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 1997, 80, 607–616.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Scott S, Bai W, Yerneni KK, Nadler J. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 1999, 33, 378–384.
   PubMedGoogle Scholar
• Nahmias C, Strosberg AD. The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci 1995, 16, 223–225.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 2002, 35, 1001–1015.
   PubMed Web of Science ®Google Scholar
• Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997, 272, 24684–24690.
   Google Scholar
• Schindler CW. Series introduction. JAK–STAT signaling in human disease. J Clin Invest 2002, 109, 1133–1137.
   PubMed Web of Science ®Google Scholar
• Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998, 93, 827–839.
   PubMed Web of Science ®Google Scholar
• Becker S, Groner B, Müller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998, 394, 145–151.
   PubMed Web of Science ®Google Scholar
• Sandberg EM, Wallace TA, Godeny MD, VonDerLinden D, Sayeski PP. Jak2 tyrosine kinase: a true jak of all trades? Cell Biochem Biophys 2004, 41, 207–232.
   PubMedGoogle Scholar
• Saito Y, Berk BC. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 2001, 33, 3–7.
   PubMed Web of Science ®Google Scholar
• Seki Y, Kai H, Shibata R, Nagata T, Yasukawa H, Yoshimura A, Imaizumi T. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000, 87, 12–18.
   PubMedGoogle Scholar
• Inaba T, Ishibashi S, Gotoda T, Kawamura M, Morino N, Nojima Y, Kawakami M, Yazaki Y, Yamada N. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 1996, 45, 507–512.
   PubMed Web of Science ®Google Scholar
• Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 1996, 16, 1759–1769.
   PubMed Web of Science ®Google Scholar
• Cetin A, Ozturk OH, Tokay A, Akçit F, Caglar S, Yesilkaya A. Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells. Pharmacology 2007, 79, 27–33.
   PubMed Web of Science ®Google Scholar
• Xia P, Kramer RM, King GL. Identification of the mechanism for the inhibition of Na+,K+-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 1995, 96, 733–740.
   PubMedGoogle Scholar
• Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC. Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol Cell Biol 2001, 21, 6387–6394.
   PubMed Web of Science ®Google Scholar
• Marrero MB, Fulton D, Stepp D, Stern DM. Angiotensin II-induced signaling pathways in diabetes. Curr Diabetes Rev 2005, 1, 197–202.
   PubMedGoogle Scholar
• Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol, Cell Physiol 2007, 292, C82–C97.
   PubMed Web of Science ®Google Scholar
• Barry SP, Townsend PA, Latchman DS, Stephanou A. Role of the JAK–STAT pathway in myocardial injury. Trends Mol Med 2007, 13, 82–89.
   PubMed Web of Science ®Google Scholar
• Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 1999, 274, 32382–32386.
   Google Scholar
• Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 375, 247–250.
   PubMed Web of Science ®Google Scholar
• Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 2002, 61, 1605–1616.
   PubMedGoogle Scholar
• Shaw S, Wang X, Redd H, Alexander GD, Isales CM, Marrero MB. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem 2003, 278, 30634–30641.
   PubMed Web of Science ®Google Scholar
• Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998, 76, 21–31.
   PubMed Web of Science ®Google Scholar
• Hall JL, Matter CM, Wang X, Gibbons GH. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ Res 2000, 87, 574–580.
   PubMed Web of Science ®Google Scholar
• Williams B, Tsai P, Schrier RW. Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 1992, 90, 1992–1999.
   PubMed Web of Science ®Google Scholar
• Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996, 149, 2095–2106.
   PubMed Web of Science ®Google Scholar
• Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991, 266, 15771–15781.
   PubMed Web of Science ®Google Scholar
• Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 1995, 270, 12563–12568.
   PubMed Web of Science ®Google Scholar
• Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE. Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 2004, 44, 195–202.
   PubMed Web of Science ®Google Scholar
• Galdiero M, Vitiello M, D’Isanto M, Raieta K, Galdiero E. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. Cytokine 2006, 36, 218–228.
   PubMedGoogle Scholar
• Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, Bolli R. Role of the protein kinase C-ϵ-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 2005, 112, 1971–1978.
   PubMed Web of Science ®Google Scholar